EUVIMEDEUVIMED entdecken
Übersichtsarbeit

cGAS–STING Signaling in Acute Myeloid Leukemia: Biology, Pathophysiology, and Therapeutic Implications

Satyaki Bhowmik, Subhadeep Ghosh, Amitava Sengupta

Experimental Hematology · 2026

DOI: 10.1016/j.exphem.2026.105490 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Experimental Hematology, 2026. Verfasst von Satyaki Bhowmik und 2 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell & Leukemia lab, CSIR-Indian Institute of Chemical Biology, IICB-Translational Research Unit of Excellence, Salt Lake, Kolkata- 700091, West…. Hauptthemen laut MEDLINE: cGAS-STING Signaling Pathway, Leukemia, Myeloid, Acute, Nucleotidyltransferases, Membrane Proteins. Die Arbeit nennt 85 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, Indo-French Centre for the Promotion of Advanced Research, Lady Tata Memorial Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway is a key component of the innate immune machinery, that detects the presence of cytosolic dsDNA and initiates type I interferon-driven inflammation, resulting in downstream immune responses. In cancer, aberrant activation or suppression of this signaling pathway connects genomic instability with immune surveillance, causing context-dependent outcomes that can either augment antitumor immunity or promote tumor progression. This paradox can be exemplified using acute myeloid leukemia (AML), a genetically and clinically heterogeneous hematologic malignancy with poor long-term survival, as a model disease. Emerging evidence indicates that cGAS-STING signaling plays multifaceted roles in AML pathogenesis, influencing leukemic cell survival, stemness, inflammatory signaling, and interactions with the immune microenvironment. Genetic and epigenetic alterations common in AML engage the cGAS-STING axis to drive chronic inflammatory states, clonal expansion, and leukemic transformation, whereas acute or therapeutic activation of STING can improve antileukemic immunity. Pharmacologic STING activation promotes dendritic cell maturation, type I interferon production, and cytotoxic T cell and natural killer (NK) cell responses, and can synergize with hypomethylating agents, poly(ADP-ribose) polymerase (PARP) inhibitors, immune checkpoint blockade, and nanoparticle-based delivery systems. This review highlights current understanding of cGAS-STING biology, its contentious roles in cancer, and its specific functions in AML, highlighting therapeutic opportunities, caveats and challenges. We discuss how the delicate balance between acute and chronic STING signaling in the setting of underlying genetic regulation and immune landscape can play critical role in determining clinical outcome, positioning cGAS-STING as a promising therapeutic target and biomarker of sterile inflammation in AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

cGAS-STING Signaling PathwayLeukemia, Myeloid, AcuteNucleotidyltransferasesMembrane ProteinsHumansCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseSTING ProteinAnimalsInnate Immunity RecognitionImmunity, InnateTumor MicroenvironmentInterferon Type ISignal Transduction

Substanzen

NucleotidyltransferasesCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseSTING ProteinMembrane ProteinscGAS protein, humanSTING1 protein, humanInterferon Type I

Autor:innen und Institutionen

  • Stem Cell & Leukemia lab, CSIR-Indian Institute of Chemical Biology, IICB-Translational Research Unit of Excellence, Salt Lake, Kolkata- 700091, West Bengal, India; Academy of Scientific & Innovative Research (AcSIR), G…

Förderung

  • Council of Scientific and Industrial Research, India
  • Indo-French Centre for the Promotion of Advanced Research
  • Lady Tata Memorial Trust

Zitieren

APA

Bhowmik, S., Ghosh, S., & Sengupta, A. (2026). cGAS–STING Signaling in Acute Myeloid Leukemia: Biology, Pathophysiology, and Therapeutic Implications. Experimental Hematology. https://doi.org/10.1016/j.exphem.2026.105490

Vancouver

Bhowmik S, Ghosh S, Sengupta A. cGAS–STING Signaling in Acute Myeloid Leukemia: Biology, Pathophysiology, and Therapeutic Implications. Experimental Hematology. 2026. doi:10.1016/j.exphem.2026.105490

BibTeX
@article{Bhowmik2026,
  author = {Bhowmik, Satyaki and Ghosh, Subhadeep and Sengupta, Amitava},
  title = {cGAS–STING Signaling in Acute Myeloid Leukemia: Biology, Pathophysiology, and Therapeutic Implications},
  journal = {Experimental Hematology},
  year = {2026},
  doi = {10.1016/j.exphem.2026.105490}
}
Kostenlos starten →